KOBLIZEK, Vladimir, Branislava MILENKOVIC, Adam BARCZYK, Ruzena TKACOVA, Attila SOMFAY, Kirill ZYKOV, Neven TUDORIC, Kosta KOSTOV, Zuzana ZBOŽÍNKOVÁ, Jan ŠVANCARA, Jurij SORLI, Alvils KRAMS, Marc MIRAVITLLES and Arschang VALIPOUR. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. European Respiratory Journal. Sheffield: European Respiratory Society Journals Ltd., 2017, vol. 49, No 5, p. 1-10. ISSN 0903-1936. Available from: https://dx.doi.org/10.1183/13993003.01446-2016.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
Authors KOBLIZEK, Vladimir (203 Czech Republic), Branislava MILENKOVIC (688 Serbia), Adam BARCZYK (616 Poland), Ruzena TKACOVA (703 Slovakia), Attila SOMFAY (348 Hungary), Kirill ZYKOV (643 Russian Federation), Neven TUDORIC (191 Croatia), Kosta KOSTOV (100 Bulgaria), Zuzana ZBOŽÍNKOVÁ (203 Czech Republic, guarantor, belonging to the institution), Jan ŠVANCARA (203 Czech Republic, belonging to the institution), Jurij SORLI (705 Slovenia), Alvils KRAMS (440 Lithuania), Marc MIRAVITLLES (724 Spain) and Arschang VALIPOUR (40 Austria).
Edition European Respiratory Journal, Sheffield, European Respiratory Society Journals Ltd. 2017, 0903-1936.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 12.244
RIV identification code RIV/00216224:14110/17:00096971
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1183/13993003.01446-2016
UT WoS 000401788800005
Keywords in English Chronic obstructive pulmonary disease
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 17:32.
Abstract
Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region. Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment. 3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes. The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.
PrintDisplayed: 22/7/2024 08:28